Zeo ScientifiX, Inc. financial data

Symbol
ZEOX on OTC
Location
Davie, FL
Fiscal year end
31 October
Latest financial report
17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 37% % -3.8%
Quick Ratio 11% % 51%
Debt-to-equity -216% % -1.8%
Return On Assets -286% % -6.9%
Operating Margin -90% % 24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,777,441 shares 23%
Common Stock, Shares, Outstanding 7,614,941 shares 20%
Entity Public Float $7,129,000 USD 51%
Common Stock, Value, Issued $8,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 7,021,599 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 7,021,599 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $5,555,000 USD 22%
Cost of Revenue $1,021,000 USD 17%
Research and Development Expense $19,000 USD 217%
General and Administrative Expense $9,545,000 USD 5%
Operating Income (Loss) $5,011,000 USD 7.4%
Nonoperating Income (Expense) $121,000 USD -126%
Net Income (Loss) Attributable to Parent $5,130,000 USD -4.5%
Earnings Per Share, Basic -0.78 USD/shares -1.3%
Earnings Per Share, Diluted -0.78 USD/shares -1.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $63,000 USD 950%
Inventory, Net $502,000 USD 105%
Assets, Current $2,007,000 USD 84%
Property, Plant and Equipment, Net $564,000 USD 23%
Assets $2,571,000 USD 66%
Employee-related Liabilities, Current $667,000 USD 0%
Liabilities, Current $2,886,000 USD -14%
Liabilities $2,954,000 USD -12%
Retained Earnings (Accumulated Deficit) $68,586,000 USD -8.1%
Stockholders' Equity Attributable to Parent $383,000 USD 79%
Liabilities and Equity $2,571,000 USD 66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $471,000 USD -825%
Net Cash Provided by (Used in) Financing Activities $1,294,000 USD
Net Cash Provided by (Used in) Investing Activities $14,000 USD
Common Stock, Shares Authorized 2,500,000,000 shares 0%
Common Stock, Shares, Issued 7,614,941 shares 20%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,030,000 USD 43%
Deferred Tax Assets, Valuation Allowance $8,303,967 USD 27%
Deferred Tax Assets, Gross $8,447,733 USD 23%
Depreciation $74,000 USD 1.4%
Payments to Acquire Property, Plant, and Equipment $14,000 USD
Property, Plant and Equipment, Gross $948,000 USD 23%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $68,195,000 USD 11%
Depreciation, Depletion and Amortization $19,000 USD 5.6%
Interest Expense $86,000 USD -1.1%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%